ExeGi Pharma

ExeGi Pharma is a private, commercial-stage biotech company headquartered in Rockville, Maryland, specializing in live biotherapeutic products (LBPs) and probiotics. The company utilizes the growing scientific understanding of the microbiome to develop novel treatments for conditions with significant unmet needs, suggesting a pipeline likely focused on gastrointestinal and immune-related disorders. As a commercial entity, it has transitioned from pure R&D to generating revenue through the sale of its clinically supported products, operating in the competitive but high-growth microbiome therapeutics sector.

Platform for the development and formulation of clinically supported live biotherapeutic products (LBPs) and probiotics, leveraging microbiome science.

ExeGi operates in the competitive microbiome therapeutics space, competing with companies like Seres Therapeutics, Finch Therapeutics, and Vedanta Biosciences, as well as large pharmaceutical firms with microbiome divisions. Its differentiation is based on developing clinically supported, commercial-stage products. The landscape is fragmented, with many players targeting similar indications like C. diff and IBD.